ClydeEMarkowitzMD

Neurology • Philadelphia, PA

Neuroimmunology/Multiple Sclerosis

Associate Professor of Neurology, University Pennsylvania

Join to view full profile

Dr. Markowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Markowitz's full profile

Already have an account?

Office
3400 Civic Center Blvd
# 2
Philadelphia, PA 19104
Phone+1 215-662-3606

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1991 - 1994
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1990 - 1991
Columbia University Vagelos College of Physicians and SurgeonsClass of 1990

Certifications & Licensure

PA State Medical License 1998 - 2024
NY State Medical License 1992 - 2001
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
Completed
Phase 2
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis Start of enrollment: 2007 Jun 01
Terminated
Phase 3
Vitamin D Supplementation in Multiple Sclerosis Start of enrollment: 2012 Mar 01
Completed
Phase 3

Publications & Presentations

PubMed

Impact of insurance status on MRI phenotypes in MS.
Melissa Lynne Martin, Timothy Robert-Fitzgerald, Matthew K Schindler, Christopher Perrone, Guy Schultz
Multiple Sclerosis and Related Disorders. 2024-10-09
1 citations
Investigating Mood and Cognition in People with Multiple Sclerosis: A Prospective Study Protocol.
Elena C Cooper, Matthew K Schindler, Amit Bar-Or, Rachel B Brandstadter, Monica E Calkins
Medrxiv. 2024-10-04
5 citations
Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis.
Erica B Baller, Elizabeth M Sweeney, Matthew Cieslak, Timothy Robert-Fitzgerald, Sydney C Covitz
Biological Psychiatry. 2024-06-15

Press Mentions

New Drug, TASCENSO ODT® (Fingolimod), Launched to Meet the Needs of Multiple Sclerosis Patients in the US Left Without Essential Patient SupportFebruary 13th, 2023
Four People in the World Have a Mysterious Dementia. Could It Hold a Key to Alzheimer's?July 11th, 2021
New MS Drug Approved by FDAMarch 29th, 2017